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ReviewCell Death: Critical Control Points
lineages in C. elegans, noting they were invariant andNika N. Danial and Stanley J. Korsmeyer*
that specific cells always die (Sulston, 1976). H. RobertHoward Hughes Medical Institute
Horvitz had the insight to mutagenize C. elegans, inDana-Farber Cancer Institute
order to identify genes regulating all 131 somatic cellHarvard Medical School
deaths (Ellis and Horvitz, 1986). For their pioneering con-Boston, Massachusetts 02115
tributions to developmental genetics and programmed
cell death, the triumvirate of Brenner, Horvitz, and Sul-
ston received the 2002 Nobel Prize. Initially, two genes,Programmed cell death is a distinct genetic and bio-
ced-3 and ced-4 were noted to be absolutely requiredchemical pathway essential to metazoans. An intact
for all deaths. Whereas, another gene, ced-9 is requireddeath pathway is required for successful embryonic
to prevent cell death and was first identified by a gain-development and the maintenance of normal tissue
of-function mutation n1950, which dominantly blockedhomeostasis. Apoptosis has proven to be tightly inter-
all somatic cell death (Hengartner and Horvitz, 1994a).woven with other essential cell pathways. The iden-
ced-9 proved to be the worm homolog of the mammaliantification of critical control points in the cell death
BCL-2 oncogene, which had been shown to preventpathway has yielded fundamental insights for basic
apoptotic cell death. Moreover, mammalian BCL-2 wasbiology, as well as provided rational targets for new
capable of functioning in C. elegans (Vaux et al., 1992;therapeutics.
Hengartner and Horvitz, 1994b) suggesting the evolu-
tionary conservation of this cell death pathway.Programmed cell death (Lockshin and Williams, 1965)
The cloning and characterization of ced-3 provided aand its morphologic manifestation of apoptosis (Kerr et
critical insight into how the core apoptotic machineryal., 1972) is a conserved pathway that in its basic tenets
executes cell death. ced-3 encoded a protein related toappears operative in all metazoans. Cell deaths during
the mammalian interleukin 1 converting enzyme (ICE)embryonic development are essential for successful or-
involved in inflammation (Yuan et al., 1993). Expressionganogenesis and the crafting of complex multicellular
of either ced-3 or ICE in mammalian cells induced celltissues. The evolutionary advent of differentiated cell
death. ICE became the first member (caspase-1) of atypes may have necessitated controlling death as well
family of proteases dependent on a cysteine nucleophileas division in order to keep neighboring cells interdepen-
to cleave motifs possessing aspartic acid (aspase), thusdent and insure the proper balance of each cell lineage.
the name caspase (Thornberry and Lazebnik, 1998).Apoptosis also operates in adult organisms to maintain
Caspases are produced as inactive zymogens pos-normal cellular homeostasis. This is especially critical
sessing a large and a small subunit preceded by anin long-lived mammals that must integrate multiple
N-terminal prodomain. Two Asp cleavage sites are pro-physiological as well as pathological death signals,
cessed sequentially. The large and the small subunitswhich for example includes regulating the response to
associate to provide the active site of the enzyme. Crys-infectious agents. Gain- and loss-of-function models of
tallographic studies revealed that the active caspase isgenes in the core apoptotic pathway indicate that the
a tetramer of two heterodimers, thus containing twoviolation of cellular homeostasis can be a primary patho-
active sites. Upstream caspases known as initiators aregenic event that results in disease. Evidence indicates
capable of autocatalytic activation and generally havethat insufficient apoptosis can manifest as cancer or
a long prodomain. Downstream effector caspases needautoimmunity, while accelerated cell death is evident in
initiator caspases for their activation by transpro-
acute and chronic degenerative diseases, immunodefi-
cessing. An elegant amino acid library scan identified
ciency, and infertility. Here, we will explore some high-
an optimum four amino acid motif N-terminal to the
lights of this very active field of endeavor that witnessed aspartic acid cleavage site for each caspase which
an explosion of information over the past 15 years. Nota- helped define substrate specificity as well as specific
bly, insights from C. elegans, Drosophila, and mammals peptide inhibitors for caspases (Thornberry et al., 1997).
have focused on different portions of the death pathway, Select members (caspase-1, -11) of this protein family
suggesting that each species or perhaps the cell types are involved in specific processing of proinflammatory
and signals studied in them have emphasized selected cytokines, including IL-1 and IL-18. Other effectors, such
control points. as caspase-3 and –7, are executioners of apoptosis as
processing of their substrates leads to morphological
Programmed Cell Death in C. elegans changes associated with apoptosis, including DNA deg-
The C. elegans hermaphrodite undergoes a distinct and radation, chromatin condensation, and membrane bleb-
invariant pattern of programmed cell death where the bing. Importantly, activation of CPP32/caspase-3 was
same 131 cells out of 1090 cells die in the development shown to cause an apoptotic nuclear morphology, which
of this 959 cell nematode. Sydney Brenner envisioned could be blocked by a peptide inhibitor of CPP32 (Nich-
that this nematode would be an ideal model organism olson et al., 1995). Examination of ced-3 substrate speci-
to define specific genes responsible for developmental ficity revealed that this enzyme is more similar to mam-
cell fates (Brenner, 1974). John Sulston mapped cell malian CPP32/caspase-3 than to ICE/caspase-1 (Tewari
et al., 1995; Xue et al., 1996). Another line of evidence
for the importance of caspases in cell death came from*Correspondence: stanley_korsmeyer@dfci.harvard.edu
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Figure 1. Intrinsic Apoptotic Pathway
See text for details.
studies indicating this protease family mediates apopto- Studies of the pathway in C. elegans indicate ced-9
negatively regulates ced-4 preventing activation ofsis downstream of death receptors.
ced-3 (Shaham and Horvitz, 1996). Like other caspases,
CED-3 is an inactive zymogen until it undergoes proteo-APAF-1 and the Apoptosome
lytic activation. The death machinery is activated whenThe genetic studies in C. elegans were seminal in order-
EGL-1, a proapoptotic BH3-only BCL-2 family homolog,ing ced-4 upstream of ced-3 caspase, however ced-4
binds CED-9 at the mitochondria and displaces CED-4proved to be a “pioneer” sequence (Yuan and Horvitz,
(Conradt and Horvitz, 1998), which then translocates to1992). Biochemical fractionation of mammalian cells
the perinuclear region (Chen et al., 2000). Releaseddedicated to reconstituting apoptosis in vitro shed light
CED-4 undergoes oligomerization and bound CED-3 ison this intermediate step in the core pathway. Three
proposed to autocatalytically activate by an inducedactivities designated as Apafs (apoptotic protease acti-
proximity mechanism (Yang et al., 1998). Unlike Apaf-1,vating factors) were required to reconstitute caspase
CED-4 does not have WD40 domains and hence doesactivity in vitro. Apaf-1 turned out to be an adaptor/
not bind cytochrome c. Unlike CED-4, Apaf-1 is notamplifier molecule with homology to ced-4, while
localized to mitochondria and does not bind BCL-2,Apaf-2, and Apaf-3 were identified as cytochrome c and
supporting alternative modes of activating effector cas-caspase-9, respectively (Li et al., 1996, 1997; Zou et al.,
pases in mammalian cells.1997). Caspase-9, an initiator caspase, is capable of
self-processing when bound to Apaf-1, which provides
a complex to ensure high local concentration and proper The BCL-2 Family
The BCL-2 family of proteins constitutes a critical intra-protein conformation suitable for activation. Caspase-3,
an effector caspase, is cleaved and activated by cas- cellular checkpoint in the intrinsic pathway of apoptosis.
The founding member, the BCL-2 protooncogene, waspase-9. Structure/function studies have offered a so-
phisticated model for caspase-9 activation. Apaf-1 first identified at the chromosomal breakpoint of t(14;18)
bearing human follicular B cell lymphoma (Bakhshi etbinds cytochrome c via its WD40 domains. Elegant stud-
ies revealed that upon binding to cytochrome c, Apaf-1 al., 1985; Cleary and Sklar, 1985; Tsujimoto et al., 1985).
Expression of BCL-2 proved not to promote cell prolifer-becomes competent to recruit caspase-9 in the pres-
ence of ATP/dATP. This interaction is mediated by cas- ation, like other oncogenes of that day, but instead
blocked cell death following multiple physiological andpase recruitment domains (CARD) present in both
Apaf-1 and caspase-9 (Li et al., 1997). The CARD domain pathological stimuli (McDonnell et al., 1989; Vaux et al.,
1988). Specifically, the plasma membrane blebbing, vol-of Apaf-1 is usually bound by 2 of its WD40 domains and
is dislodged when cytochrome c binds WD40 domains ume contraction, nuclear condensation, and endo-
nucleolytic cleavage of DNA termed apoptosis (Kerr etwithin Apaf-1. Subsequent binding of ATP/dATP to
Apaf-1 is proposed to cause a conformational change al., 1972) was blocked by BCL-2, which unexpectedly
localized to the mitochondrion, nominating this intra-facilitating heptamer assembly in the shape of a wheel,
known as the apoptosome (Acehan et al., 2002). The cellular organelle for a prominent role in apoptosis
(Hockenbery et al., 1990). As a stringent test of BCL-2’sCARD and CED-4 homology domains form the hub,
while the spokes consist of WD40 domains, and procas- oncogenic activity, transgenic mice bearing a BCL-2-
immunoglobulin minigene, that recapitulates the t(14;18)pase-9 binds the hub (Figure 1).
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developed a polyclonal follicular hyperplasia comprised active BAK that resides at the mitochondria also under-
goes an allosteric conformational activation in responseof resting B cells, which accumulate because of ex-
tended cell survival not increased proliferation (McDon- to death signals, which includes its oligomerization and
the permeabilization of the MOM with release of inter-nell et al., 1989). Over time, such BCL-2-Ig mice progress
to life-threatening high grade, monoclonal lymphoma in membrane space (IMS) proteins including cytochrome
c. The precise mechanism whereby IMS proteins arewhich their resistance to apoptosis is often spontane-
ously complemented by the activation of c-myc (McDon- released is still under active investigation. One model
holds that oligomerized BAX or BAK may form poresnell and Korsmeyer, 1991). When bcl-2/myc doubly
transgenic mice were created, they developed undiffer- capable of releasing cytochrome c. This thesis has ori-
gins in the structural similarity between BCL-2 familyentiated hematopoietic leukemia (Strasser et al., 1990).
This potent synergy of a proliferative aberration plus molecules and the pore-forming helices of bacterial tox-
ins (Muchmore et al., 1996) and evidence that BAX canan apoptotic defect has subsequently proven common,
perhaps even universal to cancer. Loss-of-function anal- form channels in artificial membranes and release cyto-
chrome c from liposomes. Alternatively, BCL-2 mole-ysis uncovered a critical role for BCL-2 in maintaining
normal cellular homeostasis in that Bcl-2-deficient mice cules have been proposed to interact with intrinsic mito-
chondrial proteins and trigger permeability transitiondisplay apoptosis of lymphocytes, developmental renal
cell death and loss of melanocytes (Veis et al., 1993). (PT); however, substantial cytochrome c release clearly
occurs prior to swelling or rupture of the mitochondrion.Thus, BCL-2 constituted the cardinal member of a new
category of oncogenes: regulators of cell death. Finally, more global mechanisms of MOM permeabiliza-
tion including altered membrane curvature and lipidMammals possess an entire family of BCL-2 proteins
that includes proapoptotic as well as antiapoptotic pores are also being investigated.
The BH3-only members serve as upstream sentinelsmembers. The first proapoptotic homolog, BAX, was
identified by its interaction with BCL-2 (Oltvai et al., that selectively respond to specific, proximal death, and
survival signals (Figure 1). For example, the extrinsic1993). Bax-deficient mice displayed selective expansion
of cell populations. The ratio of anti- to proapoptotic pathway is triggered by the engagement of cell surface
death receptors, which then activate caspase-8 thatmolecules such as BCL-2/BAX constitutes a rheostat
that sets the threshold of susceptibility to apoptosis for cleaves p22 BID to connect with the intrinsic death path-
way. A newly exposed glycine following cleavage in anthe intrinsic pathway, which utilizes organelles such as
the mitochondrion to amplify death signals (Figure 1). unstructured loop is N-myristoylated enhancing the
translocation and targeting of a p7/myr-p15 BID com-The BCL-2 family can be divided into three main sub-
classes, defined in part by the homology shared within plex to mitochondria. A reconstituted mitochondrial
assay reveals that tBID serves as a membrane-targetedfour conserved regions termed BCL-2 homology (BH)
1-4 domains, roughly corresponding to  helices which ligand, which requires its intact BH3 domain to trigger
oligomerization of BAK or BAX to release cytochrome cdictate structure and function. The antiapoptotic mem-
bers include BCL-2, BCL-XL (Boise et al., 1993), MCL-1 (Desagher et al., 1999; Wei et al., 2001). The proapoptotic
activity of BH3-only molecules is apparently kept in(Kozopas et al., 1993), A1 (Choi et al., 1995), and BCL-W
(Gibson et al., 1996) and display conservation in all four check by either transcriptional control or posttransla-
tional modification. For example, NOXA and PUMA areBH1-4 domains. The structure of a BCL-XL monomer
revealed that its BH1, BH2, and BH3 domains are in under p53 mediated transcriptional control in response
to DNA damage (Nakano and Vousden, 2001; Oda etclose proximity and create a hydrophobic pocket which
can accommodate a BH3 domain of a proapoptotic al., 2000; Yu et al., 2001). BAD is switched on and off
by its phosphorylation in response to growth/survivalmember (Muchmore et al., 1996; Sattler et al., 1997).
The “multidomain” proapoptotic members (BAX, BAK) factors (Zha et al., 1996), providing a connection to the
established importance of extracellular factors in pro-possess BH1-3 domains, although they appear to re-
quire an activation event, perhaps to expose the hy- moting cell survival (Raff, 1992). BIM, which is com-
plexed with dynein light chain LC8, responds to multipledrophobic face of their BH3 domain before they can
interact with BCL-XL or BCL-2. In contrast, the proapo- stimuli (Puthalakath et al., 1999). Activation of BH3-only
molecules either directly or indirectly results in the acti-ptotic molecule BID, isolated based on its ability to bind
both BAX and BCL-2, has homology only within the vation of BAX, BAK and actually requires BAX, BAK for
executing apoptosis. In contrast, antiapoptotics, suchminimal death domain, the BH3 amphipathic  helix,
prompting the title “BH3-only” (Wang et al., 1996). Cells as BCL-2 or BCL-XL, serve a principal, although perhaps
not an exclusive role of binding and sequestering BH3-doubly deficient for the pair of “multidomain” proapo-
ptotic molecules BAX and BAK proved resistant to all only molecules preventing BAX, BAK activation (Cheng
et al., 2001). This ordering is consistent with the pathwaytested intrinsic death pathway stimuli (Lindsten et al.,
2000; Wei et al., 2001). BAX and BAK together constitute in C. elegans, which places the BH3-only EGL-1 up-
stream of the multidomain CED-9 molecule (Conradta requisite gateway to the intrinsic pathway operative
at both the mitochondrion (Wei et al., 2001) and the and Horvitz, 1998).
Unresolved issues include whether all BH3-only mole-endoplasmic reticulum (ER) (Scorrano et al., 2003). In
viable cells, multidomain BAX and BAK exist as mono- cules function identically or whether subsets exist that
might reflect their marked variation in binding prefer-mers. Inactive BAX resides in the cytosol or is loosely
attached to membranes and its pocket is occupied by ences. Recently, short peptides of the  helical BH3
domains provided evidence for a two-class model inits C-terminal helix (Suzuki et al., 2000). Upon receipt of
a death signal BAX inserts into the mitochondrial outer which BAD-like BH3 regions occupy antiapoptotic pock-
ets serving as “sensitizing” domains capable of displac-membrane (MOM) as homooligomerized multimers. In-
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Figure 2. Apoptosis in Drosophila
Multiple upstream pathways regulate expres-
sion and activation of Reaper, Hid, and Grim
(RHG), three proapoptotic proteins central to
regulation of cell death in Drosophila. RHG
proteins appear to control caspase activation
by multiple mechanisms, including formation
of an apoptosome-like complex containing
Dark and Dark-independent activation of
downstream caspases through antagonizing
caspase inhibitors such as DIAP1. RHG pro-
teins may further impact caspase activation
by regulating conformational change or re-
lease of cytochrome c. Anti- and proapo-
ptotic BCL-2 family homologs in Drosophila
reside downstream or in parallel to RHG pro-
teins and further influence caspase activa-
tion. The microRNAs Bantam and Mir-14 im-
pact apoptosis in flies by suppressing Hid
and Drice, respectively. Possible pathways
are shown as dashed lines.
ing BID-like “activating” domains which induce the oli- inhibitors of apoptosis (IAPs) initially characterized as
baculovirus-encoded proteins, such as p35, that sup-gomerization, activation of BAX, BAK. Small molecules
pressed apoptosis in infected host cells (Clem et al.,or peptidomimetics that mimic BH3 domains represent
1991). A family of IAPs, including cellular homologs,prototype therapeutics targeting the apoptotic pathway.
all bear one or several signature BIR (baculovirus IAPDrosophila BCL-2 Proteins
repeat) domains thought to directly or indirectly inhibitFly homologs of BCL-2 family proteins identified to date
caspases (Salvesen and Duckett, 2002).include a proapoptotic protein Debcl/Drob-1/dBorg-1/
Structural and functional studies have provided im-dBok and an antiapoptotic protein Buffy/dBorg-2 (Fig-
portant insights into the molecular mechanism by whichure 2) (Brachmann et al., 2000; Quinn et al., 2003). Both
cellular IAPs inhibit caspase-3, -7, and -9 (Deveraux etDebcl and Buffy possess BH1-3 domains and a hy-
al., 1997; Chai et al., 2001; Huang et al., 2001; Riedl etdrophobic membrane segment for localization to the
al., 2001). A flexible linker N-terminal to the BIR2 domainmitochondrion. They have been shown to associate and
binds the substrate groove of caspase-3, -7 adopting acounteract each other—typical of BCL-2 members—
reverse orientation as compared to that of classic cas-functioning upstream of caspase activation. Whether
pase substrates, thus blocking the substrate’s accessthey act downstream of RHG proteins (see following
to the enzyme. Inhibition of the initiator caspase-9 bysection) or in a parallel pathway is still being resolved.
XIAP has a distinct molecular basis relying on directTiered Antiapoptotics: MCL-1 as an Apical
interaction of XIAP’s BIR3 domain with the small subunitCheckpoint
of caspase-9 (Srinivasula et al., 2001).Biochemical fractionation indicted MCL-1 as a cytosolic
In Drosophila, IAPs constitute a critical apoptotic con-inhibitory factor whose degradation was required to initi-
trol point. rpr, hid, and grim figure prominently in control-ate cytochrome c release following genotoxic damage
ling death in this organism (Figure 2). These genes areto HeLa cells (Nijhawan et al., 2003). Degradation of
encoded by a genomic region (H99) which when deleted,MCL-1 was needed prior to mitochondrial translocation
eliminates cell death during embryogenesis and follow-of BCL-XL and BAX. Mice conditional for the expression
ing -irradiation (White et al., 1994; Chen et al., 1996a).of MCL-1 reveal it is essential early in development and
Genetic analysis indicates that the fly apical caspaseagain later in the maintenance of resting B and T lympho-
Dronc is essential for the proapoptotic activity ofcytes, two stages heavily dependent upon cytokines.
Reaper, Hid, and Grim (RHG) proteins. Binding of DroncConsistent with this IL-7 both induced and required
or RHG proteins to Drosophila IAP, DIAP1, is mutuallyMCL-1 to mediate lymphocyte survival. At the molecular
exclusive. At their N terminus, RHG proteins contain anlevel, MCL-1 selectively counters BIM, not BAD, to pro-
IAP binding motif (IBM) also known as the RHG motiftect BAX, BAK and promote survival (Opferman et al.,
including the tetrapeptide consensus A-(V/T/I)-(P/A)-2003). Collectively, this in vivo and in vitro evidence
(F/Y/I/V/S) implicated in binding to the BIR2 domain ofsupports a notion that antiapoptotics, like their proapo-
DIAP1. Dronc competes with RHG proteins for bindingptotic counterparts, are also ordered in which MCL-1,
to the DIAP1 BIR2 domain. A 12 amino acid region be-a short half-life protein, serves as a critical upstream
tween the CARD and the protease domains of Dronccheckpoint.
mediates this binding. Subsequent to these interactions,
complex regulatory events can lead to ubiquitin-medi-
Regulatory Mechanisms Converging on Caspases: ated proteolysis of Dronc or DIAP1 with differential ef-
Lessons Learned from Flies fect on cell fate.
The regulation of caspase activation is a major strategy Degradation of DIAP1 is under complex regulation by
two distinct ubiquitin pathways. One pathway operatesby which Drosophila regulates apoptosis. This traces to
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upstream of caspases and requires the RING domain (Figure 3). These genes were further divided into two
partially redundant classes such that the most dramaticof DIAP1 (Ryoo et al., 2002; Wing et al., 2002). This is
thought to be ultimately proapoptotic by lowering the engulfment defects were seen when one gene from each
category was altered in double-mutant animals (Ellis etthreshold of caspase activation. In this case, RHG pro-
teins regulate DIAP1 ubiquitination by recruiting a ubi- al., 1991). ced-1 which encodes an engulfment receptor
(Zhou et al., 2001), ced-6 which is homologous to thequitin-conjugating E2 enzyme, UBCD1 (Ryoo et al.,
2002), or E2-like protein Morgue (Wing et al., 2002). A mammalian PTB domain-bearing adaptor GULP (Liu and
Hengartner, 1998) and ced-7 which encodes a proteinsecond pathway of ubiquitin-mediated DIAP1 degrada-
tion has been shown to reside downstream of caspases with homology to ABC-1 transporter (Wu and Horvitz,
1998a) belong in one category and help recognize apo-and operate independently of an intact DIAP1 RING do-
main. This second mechanism appears to be antiapo- ptotic cells. ced-2 (CrkII) (Reddien and Horvitz, 2000),
ced-5 (DOCK-180) (Wu and Horvitz, 1998b), ced-10ptotic and is felt to protect cells from basal caspase
activity in the absence of any death stimuli. Caspase- (small GTPase Rac-1) (Reddien and Horvitz, 2000), and
ced-12 (ELMO) (Gumienny et al., 2001) constitute themediated cleavage of DIAP1 at residue 20 uncovers an
N-terminal Asn residue, which ultimately subjects the second class of genes and influence cytoskeletal re-
modeling.protein to degradation by the N-end rule pathway (Ditzel
et al., 2003). Cleaved DIAP1 remains bound to caspases Phagocytes recognize the surface of the dying cell
most likely through an “eat me” signal. In mammalianor any other associated protein so that bound proteins
are codegraded. The compilation of these observations systems, the best characterized “eat me” signal is phos-
phatidylserine (PS) displayed on the plasma membranesuggests the manner by which DIAP1 is degraded actu-
ally matters. It is conceivable that one ubiquitin pathway of dying cells (Fadok et al., 2000). Evidence has been
marshaled for the participation of multiple engulfmentevolved to protect cells from basal caspase activation
while the other influences the switch from life to death receptors including CD91, CD14, CD36, and V3 integ-
rin, as well as the phosphatidylserine receptor (PSR)when cells receive an apoptotic signal.
Mammalian IAPs are controlled by several mecha- (Figure 3) (Savill and Fadok, 2000).
The disposal of the apoptotic corpse is plotted oncenisms, including binding of SMAC, DIABLO and OMI,
HTRA2; two mitochondrial IMS proteins released during “eat me” signals on its surface are engaged by en-
gulfment receptors. In C. elegans, the receptor encodedapoptosis (Du et al., 2000; Suzuki et al., 2001; Verhagen
et al., 2000). Both molecules possess the tetrapeptide by ced-1 clusters around the dying cell in a manner that
utilizes Ced-7 (Zhou et al., 2001). Interestingly, ABC-1,IAP binding motif (IBM) and antagonize IAP inhibition of
caspases. Structural studies indicate that a SMAC dimer the ortholog of CED-7, is believed to regulate the distri-
bution of PS in the membrane (Hamon et al., 2000).binds the BIR2 domain of XIAP and allows caspase-3
activation (Chai et al., 2000; Liu et al., 2000). In its mono- ced-7 is unique among cell engulfment genes in that it
functions both in phagocytes and apoptotic cells (Wumeric form, SMAC displaces caspase-9 from XIAP by
utilizing an IBM similar to that found in caspase-9. Inter- and Horvitz, 1998a). Binding of engulfment receptors to
apoptotic cells ultimately signals cytoskeletal events.estingly, a feed forward amplification ensures that cas-
pase-9 remains uninhibited. The IAP binding domain An interaction between the CED-1 cytoplasmic tail and
CED-6 (Su et al., 2002) may serve this role consistentof caspase-9 is released upon cleavage by activated
caspase-3 and subsequently binds to XIAP to keep XIAP with genetic studies ordering ced-1 upstream of ced-6
(Liu and Hengartner, 1998).inert (Srinivasula et al., 2001).
The extent to which IAPs and their regulatory proteins Studies in mammals have highlighted the importance
of proper disposal of corpses by phagocytic cells (Savillare essential regulators of apoptosis appears to vary
among different organisms. While RHG proteins and and Fadok, 2000). In addition to engulfment of apoptotic
cells, macrophages are important regulators of proin-IAPs in Drosophila are prominently featured (Goyal et
al., 2000), ablation of SMAC, a functional homolog of flammatory responses by releasing cytokines such as
TNF. While proinflammatory factors are necessary inRHG proteins in mammals, or deletion of XIAP in mice
immune reaction against infection, their suppressionhave indicated that apoptosis can proceed in their ab-
during apoptotic corpse clearance is essential. This issence. Mammals may use IAPs in a more cooperative
accomplished at least in part by release of anti-inflam-context. For example, in sympathetic neurons deprived
matory factors including TGF and IL-10 by macro-of NGF, release of cytochrome c alone is not sufficient
phages engaged in corpse engulfment. Furthermore,to activate the caspase cascade, but can be augmented
regulatory mechanisms help ensure that when phagocy-by the degradation of IAPs (Deshmukh et al., 2002).
tosing dendritic cells present peptides from apoptotic
corpses to T cells, no immune reaction against self pep-
tides is initiated. Defects in clearance of corpses areCell Engulfment
predicted to create a proinflammatory milieu that mayThe apoptotic pathway and the engulfment process are
predispose to autoimmune disorders.part of a continuum that helps ensure the noninflamma-
tory nature of this death paradigm. In C. elegans, phago-
cytosis can help promote cell killing and an intact en- DNA Degradation
gulfment process requires ced-3 (Hoeppner et al., 2001; Condensation and fragmentation of nuclei is a morpho-
Reddien et al., 2001). The cast orchestrating clearance logical hallmark of apoptosis. Downstream of caspase
of apoptotic cell bodies in nematodes consists of at least activation, degradation of DNA first occurs at A/T rich
regions within the nuclear scaffold sites to produce 50–seven genes, which have homologs in higher organisms
Cell
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Figure 3. Engulfment of Apoptotic Cells
The engulfment machinery in mammals and
C. elegans share evolutionarily conserved el-
ements. Proteins encoded by two partially re-
dundant categories of genes in C. elegans
involved in this process are labeled in yellow
and their mammalian counterparts are la-
beled in green.
200 kb fragments. A caspase activated DNase (CAD) believed to be mitochondrial proteins and their release
during apoptosis suggests a role for mitochondria in C.was purified (Enari et al., 1998; Liu et al., 1997) and is
normally kept in check by its inhibitor ICAD, DFF-45 elegans cell death.
which is eliminated when cleaved by caspase-3 and -7.
DNA degradation in apoptotic cells is under the regu-
lation of CAD within the dying cell and DNase II within Signal Transduction in Apoptosis
Elucidation of the pathways activated by death recep-the lysosomes of phagocytes. Loss-of-function mouse
models for CAD and DNase II revealed a prominent role tors, including Fas (APO-1/CD95) and other TNF recep-
tor family proteins have provided a major advance infor DNase II in degrading DNA during mammalian apo-
ptosis. CAD null cells can undergo apoptosis and their understanding the role of apoptosis in maintaining tissue
homeostasis, especially in the immune system. Mono-DNA is digested efficiently after engulfment by macro-
phages. DNase II-deficient cells, however, accumulate clonal antibodies, which recognized cell surface APO-
1/Fas, induced apoptotic death of the target cell (Trauthundigested DNA. Mice doubly deficient for these pro-
teins show increased undigested DNA, thought to acti- et al., 1989). The molecular cloning of this new cell sur-
face receptor, Fas, revealed a gene that mapped to thevate innate immunity and arrest T cell development.
In mammalian cells, caspase-independent apoptotic chromosomal location of a lymphoproliferative disorder
known as lpr (Itoh et al., 1991). Lpr represented a muta-DNA degradation has been attributed to two mitochon-
drial proteins endonuclease G and apoptosis-inducing tion in the Fas death receptor indicating its loss-of-
function violated cellular homeostasis (Watanabe-Fuku-factor (AIF) that translocate to the nucleus upon release
(Li et al., 2001; Susin et al., 1999). AIF induces nuclear naga et al., 1992). Expression cloning of the Fas ligand
revealed a novel TNF family member (Suda et al., 1993).condensation and large-scale DNA fragmentation and is
required for apoptosis during embryoid body cavitation The generalized lymphoproliferative, autoimmune disor-
der gld proved to be a mutant Fas ligand (FasL) (Taka-(Joza et al., 2001). Genetic studies indicate that nuclear
translocation of AIF is dependent upon poly (ADP- hashi et al., 1994). The cloning of TNF and TNF receptors
(Tartaglia et al., 1993) together with Fas and FasL pro-ribose) polymerase-1 (PARP-1) (Yu et al., 2002). PARP-1
attaches poly ADP-ribose to nuclear proteins such as pelled an explosion of studies detailing the signal trans-
duction pathways downstream of death receptors.histones and its activation leads to apoptosis under
several conditions, including DNA damage. AIF function Death receptors rely on signaling proteins possessing
a distinct set of modular protein motifs capable of homo-is in turn required for PARP-1 proapoptotic activity.
Precisely how AIF and endonuclease G affect DNA typic interaction, including death domains (DD) and
death effector domains (DED) (Itoh and Nagata, 1993;degradation is not fully understood. Genetic studies in
C. elegans suggest that they may work in concert. How- Tartaglia et al., 1993; Hsu et al., 1995). Remarkably,
structural studies of DD and DED domains have revealedever, unlike their mammalian counterpart, worm AIF and
endonuclease G function in a caspase-dependent man- that their overall fold is very similar to that of the CARD
domain (Fesik, 2000) indicative of an evolutionarily con-ner. In C. elegans, genes implicated in apoptotic DNA
degradation include the DNase II nuc-1 (Wu et al., 2000), served structure in the assemblage of proapoptotic cas-
cades. Nature exploited the necessity for such domainswah-1 (AIF) (Wang et al., 2002), and cps-6 (endonuclease
G) (Parrish et al., 2001). WAH-1 and CPS-6 are both by evolving antagonistic decoy receptors which seques-
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Figure 4. Extrinsic Death Receptor Pathways
The distinct composition of the Death-Inducing-Signaling Complex (DISC) downstream of the various death receptors TNFR1, CD95, and
DR4/5 is illustrated.
ter death ligands but cannot propagate downstream play relative sensitivity to TRAIL-mediated apoptosis
and recent reports have highlighted the importance ofsignals due to nonfunctional or absent death domains.
Fas, which is preassembled as a trimer, undergoes a mitochondrial/postmitochondrial program. DISC com-
plex formation and BID cleavage downstream of DR4/5a conformational change following ligand binding and
assembles on its cytoplasmic tail a signaling complex is similar to the Fas pathway (Figure 4).
In addition to cell death, signaling by death receptorsknown as the DISC (Death-Inducing Signaling Complex)
(Muzio et al., 1996) (Figure 4). The adaptor FADD/MORT, has been reported to activate proliferation in select set-
tings. The decision between apoptosis versus survivalbearing both DD and DED motifs, binds the DD of Fas
and recruits procaspase-8 via its DED domain (Kischkel appears to be governed in part by differential complex
formation between various DD or DED proteins. In theet al., 1995). Activation of caspase-8 in the DISC com-
plex is believed to follow an “induced proximity” model case of TNFR1 (Figure 4), a recent report indicates vari-
ous DD-containing proteins can form distinct complexeswhere high local concentration of procaspase-8 leads
to its autoproteolytic activation and subsequent activa- in a temporal manner once the receptor is activated
(Micheau and Tschopp, 2003). A TNFR1 complex pos-tion of caspase-3 and -7. Fas-induced apoptosis can
follow two pathways (Scaffidi et al., 1998). In type I cells, sessing the DD-containing protein TRADD, TRAF2,
cIAP1, and the kinase RIP1 (known as complex I) assem-such as thymocytes in-vitro, Fas-induced apoptosis is
refractory to BCL-2 since sufficient caspase-8 cleavage bles at the plasma membrane within minutes after acti-
vation in order to recruit IKK leading to NF-kB activationand activation of caspase-3, -7 occurs. In type II cells,
such as hepatocytes, BCL-2 blocks Fas-mediated death and survival. In a second step, complex II forms after
the TRADD-based complex dissociates from the recep-as a mitochondrial amplification loop is required in which
caspase-8-mediated cleavage of BID results in its trans- tor and recruits FADD and the initiator caspase-8. In
this model, the balance of effects by complex I versuslocation to mitochondria and cytochrome c release in
order to generate sufficient effector caspase activity to II rests with cFLIP, an inhibitor of caspase-8. When com-
plex I NF-B activation is sufficient, adequate cFLIP iskill such cells (Li et al., 1998; Luo et al., 1998). This
is consistent with the susceptibility of thymocytes but expressed to inhibit caspase-8 of complex II. By this
model, complex II can mediate apoptosis only whenresistance of hepatocytes to Fas-mediated death in Bid-
deficient and Bax, Bak doubly deficient mice (Lindsten complex I-mediated NF-B activation is insufficient.
Depending on their biochemical milieu, DED-con-et al., 2000; Wei et al., 2001; Yin et al., 1999).
Another set of death receptors (DR 4/5) have been taining proteins coordinately regulate lymphocyte ho-
meostasis. Humans with caspase-10 deficiency as wellcharacterized that share a different death ligand, known
as Apo2L,TRAIL (TNF-Related Apoptosis Inducing Li- as those with heterozygous Fas mutations develop auto-
immune lymphoproliferative syndrome (ALPS) markedgand) (Ashkenazi and Dixit, 1998). Cancer cells may dis-
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by defective lymphocyte apoptosis and autoimmunity, In addition to the UPR, the cell’s response to mis-
folded proteins can utilize ER-Associated Degradationwhereas caspase-8 mutations lead to a distinct disorder
involving defects in T, B, NK cell activation, and immuno- (ERAD) through the ubiquitin pathway. Recent insight
implicated defects in the ubiquitin pathway in somedeficiency (Chun et al., 2002; Siegel et al., 2000; Wang
et al., 1999). Although, caspase-8 and -10 are both in- forms of Parkinson’s Disease. Mutations in the E3 ubi-
quitin ligase Parkin causes the death of dopaminergicvolved in the DISC complex, the human diseases imply
an additional function for caspase-8 in regulation of lym- neurons in autosomal recessive juvenile parkinsonism
(AR-JP) (Kitada et al., 1998). Parkin binds to E2 enzymesphocyte proliferation. One model for further testing pro-
poses that the location and extent of protein-protein at the ER. The G protein-coupled receptor Pael was
identified as a Parkin substrate. Consistent with thisinteractions mediated by DED-containing proteins de-
termines a “cell renewal set point” to integrate the path- finding, aggregates of Pael are detected in brains from
AR-JP patients.ways of apoptosis and proliferation.
Protein Quality as a Checkpoint for Cell Death: Future Directions
Other Molecules that Traffic to MitochondriaRoles in Degenerative Disorders
Proper folding of proteins is aided by multiple chaper- During Apoptosis
Multiple studies have reported translocation of selectedones functioning in the endoplasmic reticulum (ER). Mis-
folded or unfolded proteins and stimuli that disrupt ER proteins including the nuclear orphan receptor TR3, p53,
JNK/SPAK, PKC, and histone H1.2 to mitochondriafunction initiate the unfolded protein response (UPR), a
stress response pathway marked by a transcriptional during apoptosis (Brenner and Kroemer, 2000). How
these molecules influence mitochondrial dysfunctionprogram ensuring upregulation of key proteins neces-
sary to restore proper “protein homeostasis” (Kaufman, during apoptosis is not known, and whether they interact
with the BCL-2 pathway or reflect unique effector path-1999). In the extreme, if proper protein folding is not
achieved, unfolded proteins can trigger apoptosis. ER ways is under evaluation.
Activation of the mitochondrial pathway of apoptosisstress has been implicated in the etiology of multiple
neurodegenerative disorders, including Huntington’s Dis- is one attractive explanation for the transcription-inde-
pendent portion of p53-influenced apoptosis (Chen etease and Alzheimer’s Disease (Mattson, 2000).
Huntington’s Disease appears to result from an aber- al., 1996b; Haupt et al., 1995). Mitochondrial transloca-
tion of p53 following DNA damage (Mihara et al., 2003)rant expansion of CAG repeats encoding a polygluta-
mine repeat in the Huntingtin protein. The mutant protein and its ability to engage BCL-2 family proteins to regu-
late cytochrome c release have been noted (Chipuk etpathogenesis involves caspase-8 activation (Sanchez
et al., 1999), which is thought to occur because of an al., 2004).
An unexpected molecule, histone H1.2, has recentlyaltered complex formed by mutant Huntingtin protein
(Gervais et al., 2002). Under normal circumstances, been implicated in a mitochondrial pathway of apoptosis
(Konishi et al., 2003). Histone H1.2 is released into theHuntingtin forms a complex with Huntingtin interacting
protein 1 (Hip1), clathrin and AP2, possibly to regulate cytosol upon DNA double-strand breaks in a p53-depen-
dent manner. Histone H1.2 traffics to the mitochondriavesicular transport during neurotransmitter release. Mu-
tant Huntingtin is in a different complex containing Hip1, and while it possesses no obvious BH3 domain, BAK
oligomerization, and cytochrome c release follow. Thesecaspase-8, and the DED-containing protein Hippi lead-
ing to caspase-8 and subsequent caspase-3 activation. observations suggest an enticing model in which the
linker histone H1.2 could serve as a signaling intermedi-One model holds that active caspase-3 cleaves Hunting-
tin into self-aggregating fragments that prove toxic to ate, sensing changes in chromatin status, and communi-
cating this to the apoptotic machinery at the mitochon-the affected neurons. Many questions remain, including
whether this complex can account for all parameters drion.
Intrinsic Apoptotic Pathway Operatesof damage including the mitochondrial dysfunction in
Huntington’s Disease. at Organelles
It is striking how many of the critical control steps inInduction of apoptosis by malfolded proteins in Alz-
heimer’s disease and disorders associated with prion the intrinsic apoptotic pathway are localized to the sur-
face of intracellular organelles. The mitochondria andproteins involves abnormal ER Ca2 signaling. In Alzhei-
mer’s Disease, neurotoxicity has been attributed to amy- the endoplasmic reticulum (ER) are best documented,
but localization of BCL-2 members to the nuclear mem-loid- peptides (Yankner et al., 1990). Under normal con-
ditions, amyloid precursor protein (APP) is cleaved by brane and translocation of CED-4 to the outer nuclear
membrane raises questions about that locale as well. secretase, released in the extracellular space leading
ultimately to activation of cyclic GMP-activated protein These observations have prompted inquiries into
whether there may be a more overarching rationale forkinase, NF-B activation, and the survival of cells. Neu-
rotoxicity ensues when instead of the  secretase- the localization of apoptosis at organelles.
An ER Gateway to Apoptosiscleaved APP, amyloid- peptides accumulate. This has
been traced to alterations of one of 3 genes: APP, per- Accumulating evidence suggests that in addition to mi-
tochondria, the ER serves as an important apoptoticsenilins 1, or 2. Amyloid- peptides cause lipid peroxida-
tion, increased Ca2 release by ryanodine or IP3 recep- control point. Antiapoptotic BCL-2 and proapoptotic
BAX, BAK also localize to the ER. Overexpression oftors, and are associated with activation of caspase-12
and mitochondrial dysfunction (Mattson, 2000; Naka- BCL-2 was noted to prevent cell death by the passive
release of ER Ca2 when thapsigargin was used to blockgawa et al., 2000).
Review
213
the sarcoplasmic/endoplasmic reticulum Ca2 ATPase (Shimizu et al., 1999). Other evidence supports BCL-XL
opposing VDAC closure, perhaps by preventing mito-(SERCA) reuptake pump (Lam et al., 1994). Either over-
expression of BCL-2 or loss of BAX, BAK leads to re- chondrial alterations in response to death stimuli (Vander
Heiden et al., 1997). A recent finding implicated VDAC-2duced resting ER Ca2 concentrations and a secondary
decrease in Ca2 uptake by mitochondria (Pinton et al., as a negative regulator of a BAK-driven apoptotic pro-
gram (Cheng et al., 2003). Genetic loss of function stud-2000; Scorrano et al., 2003). Selective reconstitution of
individual organelles enabled the classification of death ies, together with reconstitution assays, indicate that
VDAC-2, amongst the three mammalian VDAC isoforms,signals based on their dependence on an ER Ca2 gate-
way and/or a mitochondrial gateway to apoptosis (Scor- is a specific inhibitor of the potentially lethal BAK mole-
cule in viable cells. This physical link between the corerano et al., 2003). Signals reliant upon the ER gateway
include the Ca2-dependent lipid second messengers apoptotic pathway and mitochondrial physiology raises
a question for future pursuit as to whether BAK recipro-such as C2-ceramide and arachidonic acid as well as
pathologic oxidative stress. In contrast, activated BH3- cally influences VDAC-2-mediated metabolic function.
An Intraorganelle Program: Membraneonly proteins kill cells as long as BAX or BAK is present
at the mitochondria irrespective of Ca2 stores. Finally, Remodeling and Morphology
Studies of the kinetics of cytochrome c release in re-a number of classic death signals utilize both gateways.
Why the Mitochondrion: Integration of Cellular sponse to apoptotic stimuli indicated that the release
can be rapid and the extent remarkably completeMetabolism and Apoptosis
Cellular energy metabolism and the core apoptotic path- (Goldstein et al., 2000). However, high-voltage electron
microscopic tomography of mitochondria has revealedway are the two major determinants of cellular survival.
Growth/survival factors such as IGF-1 or IL-3 stimulate a very narrow intermembrane space (IMS) that pos-
sesses only 15%–20% of total cytochrome c. The major-glucose transport and the translocation of hexokinase to
mitochondria, stimulating glycolysis as well as inhibiting ity of cytochrome c (85%) resides in pleomorphic in-
volutions of the inner mitochondrial membrane (IMM)apoptosis (Gottlob et al., 2001; Vander Heiden et al.,
2001). Withdrawal of growth/survival factors leads to termed tubular cristae, a highly sequestered compart-
ment separated from the IMS by narrow cristae junc-metabolic decline including a decreased glycolytic rate,
lowered O2 consumption, decreased ATP levels, and tions. Permeability transition (PT) that ultimately leads
to swelling of the mitochondria, altered cristae, and sec-reduced protein production as well as triggering the
apoptotic pathway. One line of investigation suggested ondary rupture of the MOM has been noted in certain
apoptotic and necrotic cell deaths (Lemasters et al.,that these processes were distinct in that activated myr-
AKT prevented the metabolic decline and promoted cell 1998). In this fully open conformation the PT pore (PTP),
a high conductance IMM channel whose precise com-survival, but required glucose to do so. In contrast, anti-
apoptotic BCL-2 or BCL-XL blocked apoptotic death of ponents are still being explored, is permeable to solutes
up to 1500 Da (Bernardi et al., 1999). However, in mostfactor-deprived cells, but in a glucose-independent fash-
ion that did not prevent the metabolic decline. apoptotic deaths substantial cytochrome c is released
prior to any swelling of the mitochondria. Several studiesRecent studies suggest a more intimate integration
of glucose metabolism and apoptosis. At the surface of have addressed changes in the mitochondrial ultrastruc-
ture during apoptosis (Scorrano et al., 2002; von Ahsenliver mitochondria, proapoptotic BAD nucleates a mac-
romolecular complex containing glucokinase (hexoki- et al., 2000). In one model the BH3-only molecule tBID
induced striking remodeling of the IMM, where individualnase IV), a resident kinase and phosphatase pair (PKA
and PP1), an A-kinase anchoring protein (WAVE-1) and cristae were fused and the junctions between cristae
and the IMS opened, mobilizing the stores of cyto-BAD itself (Danial et al., 2003). Bad-null mice revealed
BAD is important in regulation of mitochondrial-based chrome c. Notably, this reorganization occurred without
swelling of the organelle, but correlated with transientglucokinase (GK) activity and glucose-driven mitochon-
drial respiration. A deficit in GK activity at this organelle opening of the PTP (Scorrano et al., 2002). Apoptotic
stimuli coordinately result in the oxidation of cardiolipinin both the Bad-null and nonphosphorylatable Bad3SA
knockin mouse models manifests in a systemic diabetic and release of cytochrome c from tethered sites (Ott et
al., 2002). It will be of interest to see if this remodelingphenotype. Whether regulation of glucose metabolism
by BAD extends beyond the high Km glucose-sensing program relates to BID’s capacity to bind selected lipids
(Esposti et al., 2001).GK found in liver and pancreatic  islets to the low
Km hexokinase isoforms elsewhere awaits study. The Accumulating evidence suggests that the dynamin
family of GTPases impact mitochondrial morphologyunexpected role for BAD in regulation of glucose homeo-
stasis suggests a model in which BH3-only proteins and membrane remodeling, including events during apo-
ptosis. Dynamins are mechanoenzymes known to regulateserve as specific “sentinels” for death signals by being
embedded as integral participants in the pathways membrane pinching during vesicular/membrane trans-
port. Remarkably, RNAi knockdown of OPA-1, a mito-they monitor.
Another interrelationship of apoptosis and mitochon- chondria-resident dynamin, results in a morphology re-
sembling tBid-driven IMM remodeling and cytochromedrial function has been suggested by an interface be-
tween VDAC (voltage dependent anion channel) and c release (Olichon et al., 2003). Another dynamin family
protein Drp-1, known to regulate mitochondrial fission,BCL-2 family proteins. One school of thought proposes
BCL-XL stimulates VDAC closure while proapoptotic appears to participate in the fragmentation of this organ-
elle noted in certain cell deaths (Frank et al., 2001). TheseBAX and BAK would promote its opening and perhaps
form a BAX/VDAC hybrid channel to release cytochrome observations suggest that mechanisms dominating nor-
mal mitochondrial morphology may be coopted in apo-c, implicating VDAC as a positive regulator of apoptosis
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ptosis. Interestingly, an axis between the ER and mito- tection to B and T cells equal to that provided by a
BCL-2 transgene (Marsden et al., 2002).chondrial morphology during apoptosis is suggested by
Activation of alternative caspases including cas-the Ca2-dependent recruitment of Drp-1 to mitochon-
pase-2 has been noted in certain apoptotic paradigms,dria, proposed to be regulated by caspase cleavage of
which don’t appear to require Apaf-1 (Lassus et al.,the ER protein BAP31 (Breckenridge et al., 2003).
2002). Caspase-2 activity may represent an upstreamRegulation of Apoptosis by MicroRNAs
initiating event or may be part of a downstream amplifi-Another class of cell death regulators consists of mi-
cation loop. The final mechanism of demise in deathscroRNAs, which are capable of dampening translation of
that do not utilize the apoptosome and perhaps not evenapoptotic components in a rapid and reversible fashion.
caspases needs further resolution. Possibilities includeTwo such microRNAs have been identified in the Dro-
metabolic deaths resulting from irreversible damage tosophila cell death pathway (Figure 2). Bantam binds
organelles including mitochondria and ER, other apo-the 3UTR region of hid and suppresses its translation
ptogenic factors released from mitochondria (OMI,independently of the Ras/MAPK pathway (Brennecke et
ENDO G, or AIF) that run caspase-independent deaths,al., 2003). Mir-14 is a microRNA regulating the Drosoph-
or a novel path to activate alternative caspases. Oneila caspase Drice (Xu et al., 2003). It will be of interest to
candidate OMI relies both on its IAP binding and serine/determine whether microRNAs regulate critical control
threonine protease activity. Neither the release nor thepoints in mammalian apoptosis.
proapoptotic activity of OMI is caspase dependent. The
release of OMI may cause caspase-independent mito-Alternative Death Pathways
chondrial dysfunction as well as inhibition of IAPs. Nota-Granzymes and Calpain
bly, a recent report indicated that the serine proteaseT cells and natural killer (NK) cells utilize a granule-
activity of OMI plays a role in maintenance of mitochon-exocytosis pathway for the elimination of virus-infected
drial homeostasis under nonapoptotic conditions, as itscells. Cytotoxic granules deliver a pore-forming protein,
loss is associated with mitochondrial dysfunction andperforin, and a family of serine proteases known as gran-
neurodegeneration (Jones et al., 2003).zymes into a tightly sealed intercellular synapse, pre-
Additional Death Pathways in C. eleganssumably to ensure their selective uptake into target cells.
Several observations suggest that alternative death path-Gene knockouts coupled with biochemistry are reveal-
ways may exist in C. elegans. One candidate is a newlying distinct apoptotic pathways downstream of each
discovered participant, icd-1 (inhibitor of cell death) thatgranzyme. Granzyme B can cleave caspase-3, but also
modulates apoptosis in a ced-3-independent but ced-4-cleaves other substrates including BID and ICAD which
dependent manner (Bloss et al., 2003).Perhaps anotherresults in activation of the CAD DNase as well as alterna-
caspase is involved or perhaps icd-1 function is cas-tive pathways of apoptosis (Heusel et al., 1994; Alimonti
pase-independent. icd-1 encodes the  subunit of theet al., 2001). Granzyme A targets the SET complex re-
NAC (nascent polypeptide associated complex) sug-sulting in the degradation of selected components, free-
gesting that functions attributed to NAC, including pro-ing the NM23-H1 DNase and resulting in single-stranded
tein translation, folding, and translocation to mitochon-
DNA nicks (Lieberman, 2003). Granzyme C induces yet
dria may relate to the death inhibitory capacity of icd-1.
another caspase-independent death distinct from either
Necrotic Death
granzyme A or B. Notably, the Ca2-dependent cysteine
Necrotic cell death occurs following a wide variety of
protease, calpain also shares some common substrates cellular injuries. In distinction from apoptosis, necrosis
with the caspases including cleavage of caspases them- is characterized by distortion and degradation of organ-
selves (Gil-Parrado et al., 2002). Perhaps further elucida- elles and cellular swelling (Kerr et al., 1972). While much
tion of these protease-induced deaths will uncover remains to be learned about the genetic and biochemical
caspase-independent programs, that while triggered by pathways of necrosis downstream of the individual in-
granzymes, are also intended to operate within cells sults, studies examining excitotoxic neuronal deaths,
following intrinsic death signals. including those following ischemia, have proven instruc-
Apoptosome-Independent Death tive. Excess glutamate hyperactivates NMDA channels
In the extrinsic pathway, type I cells can run a direct, with consequent increase in intracellular Ca2 and Ca2-
initiator (caspase-8) to effector (caspase-3) cascade. dependent pathways (Nicotera et al., 1997). A necrotic
The inability of caspase inhibitors to completely protect death model in C. elegans which results from a mutant
cells and their organelles from damage following intrin- degenerin Na2 channel MEC-4 is reminiscent of mam-
sic death signals suggested that caspase-independent malian excitotoxic death. Notably, a genetic screen for
death might also occur. It is also plausible for the intrin- suppressors of these deaths identified four genes
sic pathway that mechanisms to activate caspases be- known to regulate ER Ca2: calreticulin, an intralumenal
yond the apoptosome might exist. Deletion of the down- ER Ca2 binding protein; calnexin, an ER Ca2 binding
stream effectors Apaf-1 or caspase-9 initially protects chaperone; the IP3R Ca2 release channel; and the rya-
from apoptotic stimuli, yet cells can go on to die without nodine receptor, another ER Ca2 release channel (Xu
measurable caspase activity, but with substantial organ- et al., 2001). This argues that the serial steps in necrotic
elle dysfunction. In contrast, cells doubly deficient for cell death are also definable and will ultimately yield
BAX, BAK demonstrated long-term resistance indicating targets for therapeutic intervention.
the most profound commitment point to apoptosis is Autophagy
upstream at the BAX, BAK gateway proximal to organ- Autophagy is a documented pathway of disposal for
elle damage (Cheng et al., 2001). Consistent with this, intracellular organelles that has also been implicated
in cell death. In particular, macrophagy is a dynamicneither Apaf-1 nor caspase-9 deficiency afforded pro-
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chromosome 14 and near a transcriptional unit on 18. Cell 41,process of membrane engulfment in which portions of
899–906.the cytoplasm are sequestered within double membrane
Bernardi, P., Scorrano, L., Colonna, R., Petronilli, V., and Di Lisa,vesicles known as autophagosomes. Morphologically
F. (1999). Mitochondria and cell death. Mechanistic aspects andthe process is similar from yeast to mammals. The bio-
methodological issues. Eur. J. Biochem. 264, 687–701.
genesis and consumption of such vesicles has been
Bloss, T.A., Witze, E.S., and Rothman, J.H. (2003). Suppression ofdivided into four distinct steps: induction and cargo
CED-3-independent apoptosis by mitochondrial betaNAC in Caeno-
packaging; formation and completion; docking and fu- rhabditis elegans. Nature 424, 1066–1071.
sion; and breakdown. Genetic screens in yeast identified
Boise, L.H., Gonzalez-Garcia, M., Postema, C.E., Ding, L., Lindsten,
overlapping set of genes designated apg (autophagy) T., Turka, L.A., Mao, X., Nunez, G., and Thompson, C.B. (1993).
and aut (autophagocytosis) (Klionsky and Emr, 2000). bcl-x, a bcl-2-related gene that functions as a dominant regulator
of apoptotic cell death. Cell 74, 597–608.Of these, apg-6 functions in multiple cellular processes,
is required to induce autophagy upon starvation and is Brachmann, C.B., Jassim, O.W., Wachsmuth, B.D., and Cagan, R.L.
(2000). The Drosophila bcl-2 family member dBorg-1 functions inhomologous to Beclin, a tumor suppressor in mammals,
the apoptotic response to UV-irradiation. Curr. Biol. 10, 547–550.and to a gene required in C. elegans to complete dauer
Breckenridge, D.G., Stojanovic, M., Marcellus, R.C., and Shore, G.C.morphogenesis (Liang et al., 1999). Certain cell deaths,
(2003). Caspase cleavage product of BAP31 induces mitochondrialfor example the elimination of intersegmental muscles
fission through endoplasmic reticulum calcium signals, enhancingduring morphogenesis, is more reminiscent of autoph-
cytochrome c release to the cytosol. J. Cell Biol. 160, 1115–1127.
agy than apoptosis. The induction of autophagy is pro-
Brennecke, J., Hipfner, D.R., Stark, A., Russell, R.B., and Cohen,
minently controlled by the nutrient sensing mTOR ki- S.M. (2003). bantam encodes a developmentally regulated microRNA
nase. Obvious overlaps in signal transduction pathways that controls cell proliferation and regulates the pro-apoptotic gene
whereby the PI3-kinase and mTOR paths can influence hid in Drosophila. Cell 113, 25–36.
shared intermediates, such as p70S6K, suggest autoph- Brenner, S. (1974). The genetics of Caenorhabditis elegans. Genet-
agy and apoptosis may prove to be coordinated. ics 77, 71–94.
Brenner, C., and Kroemer, G. (2000). Apoptosis. Mitochondria–the
death signal integrators. Science 289, 1150–1151.Conclusions
Chai, J., Du, C., Wu, J.W., Kyin, S., Wang, X., and Shi, Y. (2000).Our talented colleagues in this field have marshaled
Structural and biochemical basis of apoptotic activation by Smac/an extraordinary effort that uncovered the many truths
DIABLO. Nature 406, 855–862.governing cell death. In return, the identification of criti-
Chai, J., Shiozaki, E., Srinivasula, S.M., Wu, Q., Datta, P., Alnemri,cal control points in the apoptotic pathway has provided
E.S., Shi, Y., and Dataa, P. (2001). Structural basis of caspase-7
rational targets for the development of a new generation inhibition by XIAP. Cell 104, 769–780.
of therapeutics. Inhibitors that block caspase activity,
Chen, P., Nordstrom, W., Gish, B., and Abrams, J.M. (1996a). grim,
molecules that intervene at the BCL-2 control point, and a novel cell death gene in Drosophila. Genes Dev. 10, 1773–1782.
mimetics of the small RHG motif that binds IAPs are but Chen, X., Ko, L.J., Jayaraman, L., and Prives, C. (1996b). p53 levels,
three examples of compounds under active develop- functional domains, and DNA damage determine the extent of the
ment or clinical evaluation. Yet, much remains to be apoptotic response of tumor cells. Genes Dev. 10, 2438–2451.
done to further extend and integrate death pathways. Chen, F., Hersh, B.M., Conradt, B., Zhou, Z., Riemer, D., Gruenbaum,
We anticipate that apoptosis will become more fully Y., and Horvitz, H.R. (2000). Translocation of C. elegans CED-4 to
nuclear membranes during programmed cell death. Science 287,interwoven with the fabric of other physiological path-
1485–1489.ways it is charged with monitoring. However, history
Cheng, E.H., Wei, M.C., Weiler, S., Flavell, R.A., Mak, T.W., Lindsten,argues that the unexpected will make the greatest im-
T., and Korsmeyer, S.J. (2001). BCL-2, BCL-X(L) sequester BH3print on our understanding of cell death, and that we can
domain-only molecules preventing BAX- and BAK-mediated mito-fully expect it from this exceptional field of investigators. chondrial apoptosis. Mol. Cell 8, 705–711.
Cheng, E.H., Sheiko, T.V., Fisher, J.K., Craigen, W.J., and Korsmeyer,
Acknowledgments
S.J. (2003). VDAC2 inhibits BAK activation and mitochondrial apo-
ptosis. Science 301, 513–517.
We thank John Abrams for helpful discussion and Eric Smith for
Chipuk, J.E., Mauer, U., Green, D.R., and Schuler, M. (2004). Directeditorial assistance and the creation of the figures. We thank all our
activation of BAX by p53 mediates mitochondrial membrane per-colleagues responsible for the insights we attempted to summarize,
meabilization and apoptosis. Science, in press.noting that we were unable to fully acknowledge all the important
contributions. Choi, S.S., Park, I.C., Yun, J.W., Sung, Y.C., Hong, S.I., and Shin,
H.S. (1995). A novel Bcl-2 related gene, Bfl-1, is overexpressed
in stomach cancer and preferentially expressed in bone marrow.References
Oncogene 11, 1693–1698.
Acehan, D., Jiang, X., Morgan, D.G., Heuser, J.E., Wang, X., and Chun, H.J., Zheng, L., Ahmad, M., Wang, J., Speirs, C.K., Siegel,
Akey, C.W. (2002). Three-dimensional structure of the apoptosome: R.M., Dale, J.K., Puck, J., Davis, J., Hall, C.G., et al. (2002). Pleiotro-
implications for assembly, procaspase-9 binding, and activation. pic defects in lymphocyte activation caused by caspase-8 mutations
Mol. Cell 9, 423–432. lead to human immunodeficiency. Nature 419, 395–399.
Alimonti, J.B., Shi, L., Baijal, P.K., and Greenberg, A.H. (2001). Gran- Cleary, M.L., and Sklar, J. (1985). Nucleotide sequence of a t(14;18)
zyme B induces BID-mediated cytochrome c release and mitochon- chromosomal breakpoint in follicular lymphoma and demonstration
drial permeability transition. J. Biol. Chem. 276, 6974–6982. of a breakpoint-cluster region near a transcriptionally active locus
on chromosome 18. Proc. Natl. Acad. Sci. USA 82, 7439–7443.Ashkenazi, A., and Dixit, V.M. (1998). Death receptors: signaling and
modulation. Science 281, 1305–1308. Clem, R.J., Fechheimer, M., and Miller, L.K. (1991). Prevention of
apoptosis by a baculovirus gene during infection of insect cells.Bakhshi, A., Jensen, J.P., Goldman, P., Wright, J.J., McBride, O.W.,
Science 254, 1388–1390.Epstein, A.L., and Korsmeyer, S.J. (1985). Cloning the chromosomal
breakpoint of t(14;18) human lymphomas: clustering around JH on Conradt, B., and Horvitz, H.R. (1998). The C. elegans protein EGL-1
Cell
216
is required for programmed cell death and interacts with the Bcl-2- Gumienny, T.L., Brugnera, E., Tosello-Trampont, A.C., Kinchen,
J.M., Haney, L.B., Nishiwaki, K., Walk, S.F., Nemergut, M.E., Macara,like protein CED-9. Cell 93, 519–529.
I.G., Francis, R., et al. (2001). CED-12/ELMO, a novel member of theDanial, N.N., Gramm, C.F., Scorrano, L., Zhang, C.-Y., Krauss, S.,
CrkII/Dock180/Rac pathway, is required for phagocytosis and cellRanger, A.M., Datta, S.R., Greenberg, M.E., Licklider, L.J., Lowell,
migration. Cell 107, 27–41.B.B., et al. (2003). BAD and glucokinase reside in a mitochondrial
complex that integrates glycolysis and apoptosis. Nature 424, Hamon, Y., Broccardo, C., Chambenoit, O., Luciani, M.F., Toti, F.,
952–956. Chaslin, S., Freyssinet, J.M., Devaux, P.F., McNeish, J., Marguet,
D., and Chimini, G. (2000). ABC1 promotes engulfment of apoptoticDesagher, S., Osen-Sand, A., Nichols, A., Eskes, R., Montessuit, S.,
cells and transbilayer redistribution of phosphatidylserine. Nat. CellLauper, S., Maundrell, K., Antonsson, B., and Martinou, J.C. (1999).
Biol. 2, 399–406.Bid-induced conformational change of Bax is responsible for mito-
chondrial cytochrome c release during apoptosis. J. Cell Biol. Haupt, Y., Rowan, S., Shaulian, E., Vousden, K.H., and Oren, M.
144, 891–901. (1995). Induction of apoptosis in HeLa cells by trans-activation-
deficient p53. Genes Dev. 9, 2170–2183.Deshmukh, M., Du, C., Wang, X., and Johnson, E.M., Jr. (2002).
Exogenous smac induces competence and permits caspase activa- Hengartner, M.O., and Horvitz, H.R. (1994a). Activation of C. elegans
tion in sympathetic neurons. J. Neurosci. 22, 8018–8027. cell death protein CED-9 by an amino-acid substitution in a domain
conserved in Bcl-2. Nature 369, 318–320.Deveraux, Q.L., Takahashi, R., Salvesen, G.S., and Reed, J.C. (1997).
X-linked IAP is a direct inhibitor of cell-death proteases. Nature Hengartner, M.O., and Horvitz, H.R. (1994b). C. elegans cell survival
388, 300–304. gene ced-9 encodes a functional homolog of the mammalian proto-
oncogene bcl-2. Cell 76, 665–676.Ditzel, M., Wilson, R., Tenev, T., Zachariou, A., Paul, A., Deas, E., and
Meier, P. (2003). Degradation of DIAP1 by the N-end rule pathway is Heusel, J.W., Wesselschmidt, R.L., Shresta, S., Russell, J.H., and
essential for regulating apoptosis. Nat. Cell Biol. 5, 467–473. Ley, T.J. (1994). Cytotoxic lymphocytes require granzyme B for the
rapid induction of DNA fragmentation and apoptosis in allogeneicDu, C., Fang, M., Li, Y., Li, L., and Wang, X. (2000). Smac, a mitochon-
drial protein that promotes cytochrome c-dependent caspase acti- target cells. Cell 76, 977–987.
vation by eliminating IAP inhibition. Cell 102, 33–42. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R.D., and Kors-
Ellis, H.M., and Horvitz, H.R. (1986). Genetic control of programmed meyer, S.J. (1990). Bcl-2 is an inner mitochondrial membrane protein
cell death in the nematode C. elegans. Cell 44, 817–829. that blocks programmed cell death. Nature 348, 334–336.
Ellis, R.E., Jacobson, D.M., and Horvitz, H.R. (1991). Genes required Hoeppner, D.J., Hengartner, M.O., and Schnabel, R. (2001). En-
for the engulfment of cell corpses during programmed cell death in gulfment genes cooperate with ced-3 to promote cell death in
Caenorhabditis elegans. Genetics 129, 79–94. Caenorhabditis elegans. Nature 412, 202–206.
Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., and Hsu, H., Xiong, J., and Goeddel, D.V. (1995). The TNF receptor
Nagata, S. (1998). A caspase-activated DNase that degrades DNA 1-associated protein TRADD signals cell death and NF-kappa B
during apoptosis, and its inhibitor ICAD. Nature 391, 43–50. activation. Cell 81, 495–504.
Esposti, M.D., Erler, J.T., Hickman, J.A., and Dive, C. (2001). Bid, a Huang, Y., Park, Y.C., Rich, R.L., Segal, D., Myszka, D.G., and Wu,
widely expressed pro-apoptotic protein of the Bcl-2 family, displays H. (2001). Structural basis of caspase inhibition by XIAP: differential
lipid transfer activity. Mol. Cell. Biol. 21, 7268–7276. roles of the linker versus the BIR domain. Cell 104, 781–790.
Fadok, V.A., Bratton, D.L., Rose, D.M., Pearson, A., Ezekewitz, R.A., Itoh, N., and Nagata, S. (1993). A novel protein domain required for
and Henson, P.M. (2000). A receptor for phosphatidylserine-specific apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem.
clearance of apoptotic cells. Nature 405, 85–90. 268, 10932–10937.
Fesik, S.W. (2000). Insights into programmed cell death through Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Same-
structural biology. Cell 103, 273–282. shima, M., Hase, A., Seto, Y., and Nagata, S. (1991). The polypeptide
Frank, S., Gaume, B., Bergmann-Leitner, E.S., Leitner, W.W., Robert, encoded by the cDNA for human cell surface antigen Fas can medi-
E.G., Catez, F., Smith, C.L., and Youle, R.J. (2001). The role of dy- ate apoptosis. Cell 66, 233–243.
namin-related protein 1, a mediator of mitochondrial fission, in apo- Jones, J.M., Datta, P., Srinivasula, S.M., Ji, W., Gupta, S., Zhang,
ptosis. Dev. Cell 1, 515–525. Z., Davies, E., Hajnoczky, G., Saunders, T.L., Van Keuren, M.L., et
Gervais, F.G., Singaraja, R., Xanthoudakis, S., Gutekunst, C.A., Lea- al. (2003). Loss of Omi mitochondrial protease activity causes the
vitt, B.R., Metzler, M., Hackam, A.S., Tam, J., Vaillancourt, J.P., neuromuscular disorder of mnd2 mutant mice. Nature 425, 721–727.
Houtzager, V., et al. (2002). Recruitment and activation of cas- Joza, N., Susin, S.A., Daugas, E., Stanford, W.L., Cho, S.K., Li, C.Y.,
pase-8 by the Huntingtin-interacting protein Hip-1 and a novel part- Sasaki, T., Elia, A.J., Cheng, H.Y., Ravagnan, L., et al. (2001). Essen-
ner Hippi. Nat. Cell Biol. 4, 95–105. tial role of the mitochondrial apoptosis-inducing factor in pro-
Gibson, L., Holmgreen, S.P., Huang, D.C., Bernard, O., Copeland, grammed cell death. Nature 410, 549–554.
N.G., Jenkins, N.A., Sutherland, G.R., Baker, E., Adams, J.M., and
Kaufman, R.J. (1999). Stress signaling from the lumen of the endo-
Cory, S. (1996). bcl-w, a novel member of the bcl-2 family, promotes
plasmic reticulum: coordination of gene transcriptional and transla-
cell survival. Oncogene 13, 665–675.
tional controls. Genes Dev. 13, 1211–1233.
Gil-Parrado, S., Fernandez-Montalvan, A., Assfalg-Machleidt, I.,
Kerr, J.F., Wyllie, A.H., and Currie, A.R. (1972). Apoptosis: a basicPopp, O., Bestvater, F., Holloschi, A., Knoch, T.A., Auerswald, E.A.,
biological phenomenon with wide-ranging implications in tissue ki-Welsh, K., Reed, J.C., et al. (2002). Ionomycin-activated calpain
netics. Br. J. Cancer 26, 239–257.triggers apoptosis. A probable role for Bcl-2 family members. J.
Kischkel, F.C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M.,Biol. Chem. 277, 27217–27226.
Krammer, P.H., and Peter, M.E. (1995). Cytotoxicity-dependentGoldstein, J.C., Waterhouse, N.J., Juin, P., Evan, G.I., and Green,
APO-1 (Fas/CD95)-associated proteins form a death-inducing sig-D.R. (2000). The coordinate release of cytochrome c during apopto-
naling complex (DISC) with the receptor. EMBO J. 14, 5579–5588.sis is rapid, complete and kinetically invariant. Nat. Cell Biol. 2,
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y.,156–162.
Minoshima, S., Yokochi, M., Mizuno, Y., and Shimizu, N. (1998).Gottlob, K., Majewski, N., Kennedy, S., Kandel, E., Robey, R.B., and
Mutations in the parkin gene cause autosomal recessive juvenileHay, N. (2001). Inhibition of early apoptotic events by Akt/PKB is
parkinsonism. Nature 392, 605–608.dependent on the first committed step of glycolysis and mitochon-
Klionsky, D.J., and Emr, S.D. (2000). Autophagy as a regulated path-drial hexokinase. Genes Dev. 15, 1406–1418.
way of cellular degradation. Science 290, 1717–1721.Goyal, L., McCall, K., Agapite, J., Hartwieg, E., and Steller, H. (2000).
Induction of apoptosis by Drosophila reaper, hid and grim through Konishi, A., Shimizu, S., Hirota, J., Takao, T., Fan, Y., Matsuoka, Y.,
Zhang, L., Yoneda, Y., Fujii, Y., Skoultchi, A.I., and Tsujimoto, Y.inhibition of IAP function. EMBO J. 19, 589–597.
Review
217
(2003). Involvement of histone H1.2 in apoptosis induced by DNA transgenic mice demonstrate extended B cell survival and follicular
lymphoproliferation. Cell 57, 79–88.double-strand breaks. Cell 114, 673–688.
Kozopas, K.M., Yang, T., Buchan, H.L., Zhou, P., and Craig, R.W. Micheau, O., and Tschopp, J. (2003). Induction of TNF receptor
(1993). MCL1, a gene expressed in programmed myeloid cell differ- I-mediated apoptosis via two sequential signaling complexes. Cell
entiation, has sequence similarity to BCL2. Proc. Natl. Acad. Sci. 114, 181–190.
USA 90, 3516–3520. Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pan-
Lam, M., Dubyak, G., Chen, L., Nunez, G., Miesfeld, R.L., and Distel- coska, P., and Moll, U.M. (2003). p53 has a direct apoptogenic role
horst, C.W. (1994). Evidence that BCL-2 represses apoptosis by at the mitochondria. Mol. Cell 11, 577–590.
regulating endoplasmic reticulum-associated Ca2 fluxes. Proc. Muchmore, S.W., Sattler, M., Liang, H., Meadows, R.P., Harlan, J.E.,
Natl. Acad. Sci. USA 91, 6569–6573. Yoon, H.S., Nettesheim, D., Chang, B.S., Thompson, C.B., Wong,
Lassus, P., Opitz-Araya, X., and Lazebnik, Y. (2002). Requirement S.L., et al. (1996). X-ray and NMR structure of human Bcl-xL, an
for caspase-2 in stress-induced apoptosis before mitochondrial per- inhibitor of programmed cell death. Nature 381, 335–341.
meabilization. Science 297, 1352–1354. Muzio, M., Chinnaiyan, A.M., Kischkel, F.C., O’Rourke, K., Shev-
Lemasters, J.J., Nieminen, A.L., Qian, T., Trost, L.C., Elmore, S.P., chenko, A., Ni, J., Scaffidi, C., Bretz, J.D., Zhang, M., Gentz, R., et
Nishimura, Y., Crowe, R.A., Cascio, W.E., Bradham, C.A., Brenner, al. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like prote-
D.A., and Herman, B. (1998). The mitochondrial permeability transi- ase, is recruited to the CD95 (Fas/APO-1) death–inducing signaling
tion in cell death: a common mechanism in necrosis, apoptosis and complex. Cell 85, 817–827.
autophagy. Biochim. Biophys. Acta 1366, 177–196. Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B.A.,
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., and Yuan, J. (2000). Caspase-12 mediates endoplasmic-reticulum-
Alnemri, E.S., and Wang, X. (1997). Cytochrome c and dATP-depen- specific apoptosis and cytotoxicity by amyloid-beta. Nature 403,
dent formation of Apaf-1/caspase-9 complex initiates an apoptotic 98–103.
protease cascade. Cell 91, 479–489. Nakano, K., and Vousden, K.H. (2001). PUMA, a novel pro-apoptotic
Li, H., Zhu, H., Xu, C.J., and Yuan, J. (1998). Cleavage of BID by gene, is induced by p53. Mol. Cell 7, 683–694.
caspase 8 mediates the mitochondrial damage in the Fas pathway Nicholson, D.W., Ali, A., Thornberry, N.A., Vaillancourt, J.P., Ding,
of apoptosis. Cell 94, 491–501. C.K., Gallant, M., Gareau, Y., Griffin, P.R., Labelle, M., Lazebnik,
Li, L.Y., Luo, X., and Wang, X. (2001). Endonuclease G is an apoptotic Y.A., et al. (1995). Identification and inhibition of the ICE/CED-3
DNase when released from mitochondria. Nature 412, 95–99. protease necessary for mammalian apoptosis. Nature 376, 37–43.
Liang, X.H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hib- Nicotera, P., Ankarcrona, M., Bonfoco, E., Orrenius, S., and Lipton,
shoosh, H., and Levine, B. (1999). Induction of autophagy and inhibi- S.A. (1997). Neuronal necrosis and apoptosis: two distinct events
tion of tumorigenesis by beclin 1. Nature 402, 672–676. induced by exposure to glutamate or oxidative stress. Adv. Neurol.
72, 95–101.Lieberman, J. (2003). The ABCs of granule-mediated cytotoxicity:
new weapons in the arsenal. Nat. Rev. Immunol. 3, 361–370. Nijhawan, D., Fang, M., Traer, E., Zhong, Q., Gao, W., Du, F., and
Wang, X. (2003). Elimination of Mcl-1 is required for the initiation ofLindsten, T., Ross, A.J., King, A., Zong, W.X., Rathmell, J.C., Shiels,
apoptosis following ultraviolet irradiation. Genes Dev. 17, 1475–H.A., Ulrich, E., Waymire, K.G., Mahar, P., Frauwirth, K., et al. (2000).
1486.The combined functions of pro-apoptotic Bcl-2 family members bak
and bax are essential for normal development of multiple tissues. Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita,
Mol. Cell 6, 1389–1399. T., Tokino, T., Taniguchi, T., and Tanaka, N. (2000). Noxa, a BH3-
only member of the Bcl-2 family and candidate mediator of p53-Liu, Q.A., and Hengartner, M.O. (1998). Candidate adaptor protein
induced apoptosis. Science 288, 1053–1058.CED-6 promotes the engulfment of apoptotic cells in C. elegans.
Cell 93, 961–972. Olichon, A., Baricault, L., Gas, N., Guillou, E., Valette, A., Belenguer,
P., and Lenaers, G. (2003). Loss of OPA1 perturbates the mitochon-Liu, X., Kim, C.N., Yang, J., Jemmerson, R., and Wang, X. (1996).
drial inner membrane structure and integrity, leading to cytochromeInduction of apoptotic program in cell-free extracts: requirement for
c release and apoptosis. J. Biol. Chem. 278, 7743–7746.dATP and cytochrome c. Cell 86, 147–157.
Oltvai, Z.N., Milliman, C.L., and Korsmeyer, S.J. (1993). Bcl-2 hetero-Liu, X., Zou, H., Slaughter, C., and Wang, X. (1997). DFF, a hetero-
dimerizes in vivo with a conserved homolog, Bax, that acceleratesdimeric protein that functions downstream of caspase-3 to trigger
programmed cell death. Cell 74, 609–619.DNA fragmentation during apoptosis. Cell 89, 175–184.
Opferman, J.T., Letai, A., Beard, C., Sorcinelli, M.D., Ong, C.C., andLiu, Z., Sun, C., Olejniczak, E.T., Meadows, R.P., Betz, S.F., Oost,
Korsmeyer, S.J. (2003). Development and maintenance of B and TT., Herrmann, J., Wu, J.C., and Fesik, S.W. (2000). Structural basis
lymphocytes requires anti-apoptotic MCL-1. Nature 426, 671–676.for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature
408, 1004–1008. Ott, M., Robertson, J.D., Gogvadze, V., Zhivotovsky, B., and Orren-
ius, S. (2002). Cytochrome c release from mitochondria proceedsLockshin, R.A., and Williams, C.M. (1965). Programmed cell death–I.
by a two-step process. Proc. Natl. Acad. Sci. USA 99, 1259–1263.Cytology of degeneration in the intersegmental muscles of the pernyi
silkmoth. J. Insect Physiol. 11, 123–133. Parrish, J., Li, L., Klotz, K., Ledwich, D., Wang, X., and Xue, D. (2001).
Mitochondrial endonuclease G is important for apoptosis in C. ele-Luo, X., Budihardjo, I., Zou, H., Slaughter, C., and Wang, X. (1998).
gans. Nature 412, 90–94.Bid, a Bcl2 interacting protein, mediates cytochrome c release from
mitochondria in response to activation of cell surface death recep- Pinton, P., Ferrari, D., Magalhaes, P., Schulze-Osthoff, K., Di Virgilio,
tors. Cell 94, 481–490. F., Pozzan, T., and Rizzuto, R. (2000). Reduced loading of intracellu-
lar Ca(2) stores and downregulation of capacitative Ca(2) influxMarsden, V.S., O’Connor, L., O’Reilly, L.A., Silke, J., Metcalf, D.,
in Bcl-2-overexpressing cells. J. Cell Biol. 148, 857–862.Ekert, P.G., Huang, D.C., Cecconi, F., Kuida, K., Tomaselli, K.J., et
al. (2002). Apoptosis initiated by Bcl-2-regulated caspase activation Puthalakath, H., Huang, D.C., O’Reilly, L.A., King, S.M., and Strasser,
independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. A. (1999). The pro-apoptotic activity of the Bcl-2 family member Bim
Nature 419, 634–637. is regulated by interaction with the dynein motor complex. Mol. Cell
3, 287–296.Mattson, M.P. (2000). Apoptosis in neurodegenerative disorders.
Nat. Rev. Mol. Cell Biol. 1, 120–129. Quinn, L., Coombe, M., Mills, K., Daish, T., Colussi, P., Kumar, S.,
and Richardson, H. (2003). Buffy, a Drosophila Bcl-2 protein, hasMcDonnell, T.J., and Korsmeyer, S.J. (1991). Progression from
anti-apoptotic and cell cycle inhibitory functions. EMBO J. 22, 3568–lymphoid hyperplasia to high-grade malignant lymphoma in mice
3579.transgenic for the t(14; 18). Nature 349, 254–256.
McDonnell, T.J., Deane, N., Platt, F.M., Nunez, G., Jaeger, U., Raff, M.C. (1992). Social controls on cell survival and cell death.
Nature 356, 397–400.McKearn, J.P., and Korsmeyer, S.J. (1989). bcl-2-immunoglobulin
Cell
218
Reddien, P.W., and Horvitz, H.R. (2000). CED-2/CrkII and CED-10/ mitochondria and interacts with XIAP, inducing cell death. Mol. Cell
8, 613–621.Rac control phagocytosis and cell migration in Caenorhabditis ele-
gans. Nat. Cell Biol. 2, 131–136. Suzuki, M., Youle, R.J., and Tjandra, N. (2000). Structure of Bax:
coregulation of dimer formation and intracellular localization. CellReddien, P.W., Cameron, S., and Horvitz, H.R. (2001). Phagocytosis
103, 645–654.promotes programmed cell death in C. elegans. Nature 412,198–202.
Takahashi, T., Tanaka, M., Brannan, C.I., Jenkins, N.A., Copeland,Riedl, S.J., Renatus, M., Schwarzenbacher, R., Zhou, Q., Sun, C.,
N.G., Suda, T., and Nagata, S. (1994). Generalized lymphoprolifera-Fesik, S.W., Liddington, R.C., and Salvesen, G.S. (2001). Structural
tive disease in mice, caused by a point mutation in the Fas ligand.basis for the inhibition of caspase-3 by XIAP. Cell 104, 791–800.
Cell 76, 969–976.Ryoo, H.D., Bergmann, A., Gonen, H., Ciechanover, A., and Steller,
Tartaglia, L.A., Ayres, T.M., Wong, G.H., and Goeddel, D.V. (1993).H. (2002). Regulation of Drosophila IAP1 degradation and apoptosis
A novel domain within the 55 kd TNF receptor signals cell death.by reaper and ubcD1. Nat. Cell Biol. 4, 432–438.
Cell 74, 845–853.Salvesen, G.S., and Duckett, C.S. (2002). IAP proteins: blocking the
Tewari, M., Quan, L.T., O’Rourke, K., Desnoyers, S., Zeng, Z.,road to death’s door. Nat. Rev. Mol. Cell Biol. 3, 401–410.
Beidler, D.R., Poirier, G.G., Salvesen, G.S., and Dixit, V.M. (1995).Sanchez, I., Xu, C.J., Juo, P., Kakizaka, A., Blenis, J., and Yuan, J.
Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-(1999). Caspase-8 is required for cell death induced by expanded
inhibitable protease that cleaves the death substrate poly(ADP-polyglutamine repeats. Neuron 22, 623–633.
ribose) polymerase. Cell 81, 801–809.
Sattler, M., Liang, H., Nettesheim, D., Meadows, R.P., Harlan, J.E.,
Thornberry, N.A., and Lazebnik, Y. (1998). Caspases: enemies within.Eberstadt, M., Yoon, H.S., Shuker, S.B., Chang, B.S., Minn, A.J., et
Science 281, 1312–1316.al. (1997). Structure of Bcl-xL-Bak peptide complex: recognition
Thornberry, N.A., Rano, T.A., Peterson, E.P., Rasper, D.M., Timkey,between regulators of apoptosis. Science 275, 983–986.
T., Garcia-Calvo, M., Houtzager, V.M., Nordstrom, P.A., Roy, S.,
Savill, J., and Fadok, V. (2000). Corpse clearance defines the mean-
Vaillancourt, J.P., et al. (1997). A combinatorial approach defines
ing of cell death. Nature 407, 784–788.
specificities of members of the caspase family and granzyme B.
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, Functional relationships established for key mediators of apoptosis.
K.J., Debatin, K.M., Krammer, P.H., and Peter, M.E. (1998). Two J. Biol. Chem. 272, 17907–17911.
CD95 (APO-1/Fas) signaling pathways. EMBO J. 17, 1675–1687.
Trauth, B.C., Klas, C., Peters, A.M., Matzku, S., Moller, P., Falk, W.,
Scorrano, L., Ashiya, M., Buttle, K., Weiler, S., Oakes, S.A., Mannella, Debatin, K.M., and Krammer, P.H. (1989). Monoclonal antibody-
C.A., and Korsmeyer, S.J. (2002). A distinct pathway remodels mito- mediated tumor regression by induction of apoptosis. Science
chondrial cristae and mobilizes cytochrome c during apoptosis. Dev. 245, 301–305.
Cell 2, 55–67. Tsujimoto, Y., Cossman, J., Jaffe, E., and Croce, C.M. (1985).
Scorrano, L., Oakes, S.A., Opferman, J.T., Cheng, E.H., Sorcinelli, Involvement of the bcl-2 gene in human follicular lymphoma. Science
M.D., Pozzan, T., and Korsmeyer, S.J. (2003). BAX and BAK regula- 228, 1440–1443.
tion of endoplasmic reticulum Ca2: a control point for apoptosis. Vander Heiden, M.G., Chandel, N.S., Williamson, E.K., Schumacker,
Science 300, 135–139. P.T., and Thompson, C.B. (1997). Bcl-xL regulates the membrane
Shaham, S., and Horvitz, H.R. (1996). Developing Caenorhabditis potential and volume homeostasis of mitochondria. Cell 91,
elegans neurons may contain both cell-death protective and killer 627–637.
activities. Genes Dev. 10, 578–591. Vander Heiden, M.G., Plas, D.R., Rathmell, J.C., Fox, C.J., Harris,
Shimizu, S., Narita, M., and Tsujimoto, Y. (1999). Bcl-2 family proteins M.H., and Thompson, C.B. (2001). Growth factors can influence cell
regulate the release of apoptogenic cytochrome c by the mitochon- growth and survival through effects on glucose metabolism. Mol.
drial channel VDAC. Nature 399, 483–487. Cell. Biol. 21, 5899–5912.
Siegel, R.M., Frederiksen, J.K., Zacharias, D.A., Chan, F.K., Johnson, Vaux, D.L., Cory, S., and Adams, J.M. (1988). Bcl-2 gene promotes
M., Lynch, D., Tsien, R.Y., and Lenardo, M.J. (2000). Fas preassocia- haemopoietic cell survival and cooperates with c-myc to immortalize
tion required for apoptosis signaling and dominant inhibition by pre-B cells. Nature 335, 440–442.
pathogenic mutations. Science 288, 2354–2357. Vaux, D.L., Weissman, I.L., and Kim, S.K. (1992). Prevention of pro-
grammed cell death in Caenorhabditis elegans by human bcl-2.Srinivasula, S.M., Hegde, R., Saleh, A., Datta, P., Shiozaki, E., Chai,
J., Lee, R.A., Robbins, P.D., Fernandes-Alnemri, T., Shi, Y., and Science 258, 1955–1957.
Alnemri, E.S. (2001). A conserved XIAP-interaction motif in cas- Veis, D.J., Sorenson, C.M., Shutter, J.R., and Korsmeyer, S.J. (1993).
pase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis,
Nature 410, 112–116. polycystic kidneys, and hypopigmented hair. Cell 75, 229–240.
Strasser, A., Harris, A.W., Bath, M.L., and Cory, S. (1990). Novel Verhagen, A.M., Ekert, P.G., Pakusch, M., Silke, J., Connolly, L.M.,
primitive lymphoid tumours induced in transgenic mice by coopera- Reid, G.E., Moritz, R.L., Simpson, R.J., and Vaux, D.L. (2000). Identifi-
tion between myc and bcl-2. Nature 348, 331–333. cation of DIABLO, a mammalian protein that promotes apoptosis
by binding to and antagonizing IAP proteins. Cell 102, 43–53.Su, H.P., Nakada-Tsukui, K., Tosello-Trampont, A.C., Li, Y., Bu, G.,
Henson, P.M., and Ravichandran, K.S. (2002). Interaction of CED- von Ahsen, O., Renken, C., Perkins, G., Kluck, R.M., Bossy-Wetzel,
6/GULP, an adapter protein involved in engulfment of apoptotic E., and Newmeyer, D.D. (2000). Preservation of mitochondrial struc-
cells with CED-1 and CD91/low density lipoprotein receptor-related ture and function after Bid- or Bax-mediated cytochrome c release.
protein (LRP). J. Biol. Chem. 277, 11772–11779. J. Cell Biol. 150, 1027–1036.
Suda, T., Takahashi, T., Golstein, P., and Nagata, S. (1993). Molecular Wang, K., Yin, X.M., Chao, D.T., Milliman, C.L., and Korsmeyer, S.J.
cloning and expression of the Fas ligand, a novel member of the (1996). BID: a novel BH3 domain-only death agonist. Genes Dev.
tumor necrosis factor family. Cell 75, 1169–1178. 10, 2859–2869.
Sulston, J.E. (1976). Post-embryonic development in the ventral cord Wang, J., Zheng, L., Lobito, A., Chan, F.K., Dale, J., Sneller, M., Yao,
of Caenorhabditis elegans. Philos. Trans. R. Soc. Lond. B Biol. Sci. X., Puck, J.M., Straus, S.E., and Lenardo, M.J. (1999). Inherited
275, 287–297. human Caspase 10 mutations underlie defective lymphocyte and
dendritic cell apoptosis in autoimmune lymphoproliferative syn-Susin, S.A., Lorenzo, H.K., Zamzami, N., Marzo, I., Snow, B.E., Broth-
drome type II. Cell 98, 47–58.ers, G.M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., et
al. (1999). Molecular characterization of mitochondrial apoptosis- Wang, X., Yang, C., Chai, J., Shi, Y., and Xue, D. (2002). Mechanisms
inducing factor. Nature 397, 441–446. of AIF-mediated apoptotic DNA degradation in Caenorhabditis ele-
gans. Science 298, 1587–1592.Suzuki, Y., Imai, Y., Nakayama, H., Takahashi, K., Takio, K., and
Takahashi, R. (2001). A serine protease, HtrA2, is released from the Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins,
Review
219
N.A., and Nagata, S. (1992). Lymphoproliferation disorder in mice
explained by defects in Fas antigen that mediates apoptosis. Nature
356, 314–317.
Wei, M.C., Zong, W.X., Cheng, E.H., Lindsten, T., Panoutsakopoulou,
V., Ross, A.J., Roth, K.A., MacGregor, G.R., Thompson, C.B., and
Korsmeyer, S.J. (2001). Pro-apoptotic BAX and BAK: a requisite
gateway to mitochondrial dysfunction and death. Science 292,
727–730.
White, K., Grether, M.E., Abrams, J.M., Young, L., Farrell, K., and
Steller, H. (1994). Genetic control of programmed cell death in Dro-
sophila. Science 264, 677–683.
Wing, J.P., Schreader, B.A., Yokokura, T., Wang, Y., Andrews, P.S.,
Huseinovic, N., Dong, C.K., Ogdahl, J.L., Schwartz, L.M., White, K.,
and Nambu, J.R. (2002). Drosophila Morgue is an F box/ubiquitin
conjugase domain protein important for grim-reaper mediated apo-
ptosis. Nat. Cell Biol. 4, 451–456.
Wu, Y.C., and Horvitz, H.R. (1998a). The C. elegans cell corpse
engulfment gene ced-7 encodes a protein similar to ABC transport-
ers. Cell 93, 951–960.
Wu, Y.C., and Horvitz, H.R. (1998b).C. elegans phagocytosis and
cell-migration protein CED-5 is similar to human DOCK180. Nature
392, 501–504.
Wu, Y.C., Stanfield, G.M., and Horvitz, H.R. (2000). NUC-1, a caeno-
rhabditis elegans DNase II homolog, functions in an intermediate
step of DNA degradation during apoptosis. Genes Dev. 14, 536–548.
Xu, K., Tavernarakis, N., and Driscoll, M. (2001). Necrotic cell death
in C. elegans requires the function of calreticulin and regulators of
Ca(2) release from the endoplasmic reticulum. Neuron 31,
957–971.
Xu, P., Vernooy, S.Y., Guo, M., and Hay, B.A. (2003). The Drosophila
MicroRNA Mir-14 Suppresses Cell Death and Is Required for Normal
Fat Metabolism. Curr. Biol. 13, 790–795.
Xue, D., Shaham, S., and Horvitz, H.R. (1996). The Caenorhabditis
elegans cell-death protein CED-3 is a cysteine protease with sub-
strate specificities similar to those of the human CPP32 protease.
Genes Dev. 10, 1073–1083.
Yang, X., Chang, H.Y., and Baltimore, D. (1998). Essential role of
CED-4 oligomerization in CED-3 activation and apoptosis. Science
281, 1355–1357.
Yankner, B.A., Duffy, L.K., and Kirschner, D.A. (1990). Neurotrophic
and neurotoxic effects of amyloid beta protein: reversal by tachyki-
nin neuropeptides. Science 250, 279–282.
Yin, X.M., Wang, K., Gross, A., Zhao, Y., Zinkel, S., Klocke, B., Roth,
K.A., and Korsmeyer, S.J. (1999). Bid-deficient mice are resistant to
Fas-induced hepatocellular apoptosis. Nature 400, 886–891.
Yu, J., Zhang, L., Hwang, P.M., Kinzler, K.W., and Vogelstein, B.
(2001). PUMA induces the rapid apoptosis of colorectal cancer cells.
Mol. Cell 7, 673–682.
Yu, S.W., Wang, H., Poitras, M.F., Coombs, C., Bowers, W.J., Feder-
off, H.J., Poirier, G.G., Dawson, T.M., and Dawson, V.L. (2002). Medi-
ation of poly(ADP-ribose) polymerase-1-dependent cell death by
apoptosis-inducing factor. Science 297, 259–263.
Yuan, J., and Horvitz, H.R. (1992). The Caenorhabditis elegans cell
death gene ced-4 encodes a novel protein and is expressed during
the period of extensive programmed cell death. Development
116, 309–320.
Yuan, J., Shaham, S., Ledoux, S., Ellis, H.M., and Horvitz, H.R. (1993).
The C. elegans cell death gene ced-3 encodes a protein similar to
mammalian interleukin-1 beta-converting enzyme. Cell 75, 641–652.
Zha, J., Harada, H., Yang, E., Jockel, J., and Korsmeyer, S.J. (1996).
Serine phosphorylation of death agonist BAD in response to survival
factor results in binding to 14–3-3 not BCL-X(L). Cell 87, 619–628.
Zhou, Z., Hartwieg, E., and Horvitz, H.R. (2001). CED-1 is a trans-
membrane receptor that mediates cell corpse engulfment in C. ele-
gans. Cell 104, 43–56.
Zou, H., Henzel, W.J., Liu, X., Lutschg, A., and Wang, X. (1997).
Apaf-1, a human protein homologous to C. elegans CED-4, partici-
pates in cytochrome c-dependent activation of caspase-3. Cell
90, 405–413.
